K

Active Director Director DIN 11463274
DIN 11463274 First appointment Dec 2025 Primary industry Research & Development
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2025
Shareholding value •••• Premium profile

About Kaviya

Data last updated:

Kaviya is a Director at Genprotic Biopharma Private Limited (since 2025). The company operates in Research & Development. Genprotic Biopharma Private Limited reported revenue of ₹2.3 Lakh (FY 2024).

DIN 11463274
Primary Designation Director
Industry Research & Development
First Appointment 20 Dec 2025
Largest company Genprotic Biopharma Private Limited · ₹2.3 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Genprotic Biopharma Private Limited U73100TN2020PTC135789
Director20 Dec 2025₹2.3 Lakh (FY 2024)Active

Board colleagues of Kaviya

Directorship timeline

Open interactive timeline →
Genprotic Biopharma Private Limited
Premium access

Shareholding and investment profile for Kaviya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kaviya

Kaviya currently holds 1 directorship: Genprotic Biopharma Private Limited (Director, since 20 Dec 2025, revenue ₹2.3 Lakh (FY 2024)).

Kaviya was first appointed on 20 Dec 2025 as Director at Genprotic Biopharma Private Limited.

The current boards of Kaviya's companies include Pichaimuthu Suthakaran (Genprotic Biopharma Private Limited), Srinivasan Bhavani (Genprotic Biopharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available